Jesper Ericsson appointed new CEO of Symcel

Friday, September 1, 2017

Symcel has announced that Jesper Ericsson has joined Symcel as Chief Executive Officer—with the appointment effective immediately. Ericsson was formally Director of Marketing and Sales at BioLamina, where he was responsible for direct sales both internationally and at a global and regional distributor level. During the past 10 years, Jesper has gained broad experience of the commercialization of research-based products through his work at the Unit for Bioentrepreneurship at the Karolinska Institute, Stockholm School of Entrepreneurship and as co-founder of the Stockholm BiotechBuilders Association. He holds a Ph.D. in neuroscience from the Karolinska Institute and a MSc in medical technology from the Royal Institute of Technology in Stockholm.

[Read More]

Symcel, TiKa Diagnostics and St. George’s partner

Wednesday, November 9, 2016

Symcel, the company behind a cell-based assay tool for real-time cellular bioenergetic measurements, calScreener, has partnered with TiKa Diagnostics and St. George’s University of London for the use of its microcalorimetry technology in testing mycobacteria and for antimicrobial peptide (AMP) studies. The rapid detection of antimicrobial resistance is now crucial to maximize efforts in controlling the prevalence and spread of drug resistant Mycobacterium tuberculosis (Mtb). Moreover, the development of novel agents, such as AMPs, able to combat superbugs and interfere with biofilm formation, has become a key necessity.  

[Read More]